A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
Clinical trial NCT05579548 · RECRUITING
Trial details
- NCT number
- NCT05579548
- Sponsor
- BioMarin Pharmaceutical
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-22
- Primary completion
- 2032-10-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.